All blog posts
Total 27 results for
Showing 12 out of 27 results
19 November 2024
Sustainability - trends and developments life sciences companies should be aware of
01 November 2024
EU Commission fines Teva €462.6 million for misuse of divisional patents and disparagement campaign
11 October 2024
The new UK Regulatory Innovation Office – a step in the right direction for UK life sciences
04 September 2024
CJEU finds EC's recent policy of referrals for deals below the merger thresholds illegal - more certainty for companies doing deals?
15 August 2024
H1 2024 – a steady start for biopharma M&A
07 August 2024
A new Labour Government – what might this mean for the UK life sciences industry?
01 August 2024
The EU AI Act Is In Force From Today (1 August 2024)
29 July 2024
Commission investigation into anticompetitive disparagement ends with commitments
23 July 2024
UPC finds Edwards' patent valid (as amended) – Meril's revocations dismissed
16 July 2024
UPC revokes Amgen's patent in the first case filed at the UPC
12 July 2024
The EU focuses its Industrial Policy on Critical Industries - STEP Regulation solidifies Biotechnology focus
11 July 2024
EU FRAND regulation – what next for FRAND litigation in Europe?
Showing 12 out of 27 results
View moreKey contacts
Laura Orlando
Managing Partner, Milan Office, Milan
Alan Montgomery
Partner, Head of Pharmaceuticals Sector, Chair of India Group, London and India Group
Chris Parker KC
Partner, Head of Pharmaceuticals Sector, London and Africa Group